BCT 2 1/2 Pill - white round, 7mm
Pill with imprint BCT 2 1/2 is White, Round and has been identified as Bromocriptine Mesylate 2.5 mg. It is supplied by Sandoz Pharmaceuticals Inc.
Bromocriptine is used in the treatment of Hyperprolactinemia; Acromegaly; Type 2 Diabetes; Parkinson's Disease and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Bromocriptine 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BCT 2 1/2
Bromocriptine Mesylate
- Imprint
- BCT 2 1/2
- Strength
- 2.5 mg
- Color
- White
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents, Prolactin inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00781-5325
- Inactive Ingredients
-
silicon dioxide,
corn starch,
edetate disodium,
lactose monohydrate,
magnesium stearate,
maleic acid,
povidone
Note: Inactive ingredients may vary.
See also:
Parlodel
Parlodel is used for acromegaly, hyperprolactinemia, parkinson's disease
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Cycloset
Cycloset is used to treat Type 2 Diabetes. Learn about side effects, interactions and indications.
Nuplazid
Nuplazid (pimavanserin) is an antipsychotic medicine used to treat hallucinations and delusions in ...
Pergolide
Pergolide is used for hyperprolactinemia, parkinson's disease, tourette's syndrome
More about bromocriptine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (41)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: dopaminergic antiparkinsonism agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.